Search results

Skip to results

Area of interest

Type

Status

Last updated

Your search for Orgran returned no results
Showing 31 to 45 of 302 results for organ

  1. Hypertension in pregnancy (QS35)

    This quality standard covers diagnosing and managing hypertension (high blood pressure) and pre-eclampsia during pregnancy, labour and birth. It also covers advice for women with hypertension who may become pregnant and postnatal care for women who have had hypertension or pre-eclampsia. It describes high-quality care in priority areas for improvement.

  2. Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)

    Evidence-based recommendations on machine perfusion systems and cold static storage of kidneys from deceased donors.

  3. Immunosuppressive therapy for kidney transplant in children and young people (TA482)

    Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in children and young people. The therapies are basiliximab (Simulect), immediate-release tacrolimus (Adoport, Capexion, Modigraf, Prograf, Tacni, Vivadex), mycophenolate mofetil (Cellcept and non-branded versions), rabbit anti-human thymocyte immunoglobulin (Thymoglobuline), prolonged-release tacrolimus (Advagraf, Envarsus), mycophenolate sodium (Myfortic, Ceptava), sirolimus (Rapamune), everolimus (Certican) and belatacept (Nulojix).

  4. Reasons for refusal for consent:- Why do families refuse to give permission for organ donation?

    for refusal for consent:- Why do families refuse to give permission for organ donation? Any explanatory notes(if applicable) Why this is...

  5. Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse

    cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse Any explanatory notes(if applicable) Source...

  6. Haematological cancers: improving outcomes (NG47)

    This guideline covers integrated diagnostic reporting for diagnosing haematological cancer in adults, young people and children. It also covers staffing, facilities (levels of care) and multidisciplinary teams needed for adults and young people. It aims to improve care for people with suspected or diagnosed cancer by promoting best practice on the organisation of haematological cancer services.

  7. Advanced breast cancer: diagnosis and treatment (CG81)

    This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life.

  8. What is the effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women?

    effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women? Any explanatory notes(if...

  9. The experience of consenting for organ donation:- Does a positive experience of approach and process of consent for families increase consent rates?

    Recommendation ID CG135/5 Question The experience of consenting for organ donation:- Does a positive experience of approach and process...

  10. Refractory extrapulmonary sarcoidosis: infliximab (ES4)

    Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making

  11. Patient decision aids

    urinary incontinence or pelvic organ prolapse Treating complications from mesh used for stress urinary incontinence or pelvic...

  12. Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)

    Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children.

  13. What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women?

    satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women? Any explanatory notes(if applicable)

  14. What is the most effective surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?

    surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?...

  15. What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women?

    compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women? Any explanatory notes(if applicable)